OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Capital Raises

Past Charts

Debt Capital Raises

Debt Transaction Chart

Viridian publishes weekly data and analysis on debt capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing debt (public/private, state/country location), deal size, deal structure, pricing, warrants, and credit data.

Week ended 02/10/2023

Debt Commentary

Viridian publishes weekly insights on debt capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful debt transactions of that week, and commentary on market conditions, debt deal structures, and lenders.

Week ended 02/10/2023

  • Debt accounted for 35% of trailing 4-week capital raises. We expect this ratio to be volatile because of the limited capital raise activity. Debt should average over 50% of capital raised, especially since many companies are trading at or close to their 52-week lows. We expect more companies to need to add equity kickers to their debt deals in the current capital-constrained environment.

 

The Week’s Largest Debt Raise:

    • On February 3, 2034, Entourage Health Corp (ENTG: TSX-V)(ETRGF: OTCQX) close on the second tranche of its amended and upsized credit agreement with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, providing an additional US$11.2M (C$15M).
      • The facility has a 15.25% rate with a PIK option and matures on December 31, 2024.
      • A second lien secures the credit facility on the company’s assets behind Bank of Montreal, the company’s first-priority lender, whose facility matures on June 30, 2024.
      • LiUNA has now amended and increased the loan to Entourage on five separate occasions:
        • 12/21  $15.6M
        • 4/22 $11.7M
        • 6/22 $6.9M
        • 10/22 $11.0M
        • 2/23 $11.2M
    • Proforma for the latest credit extension, LiUNA has lent Entourage approximately $83.6M, which sits behind roughly $20M first-priority debt. We can only make sense of this because LiUNA owns about 20% of Entourage. They are doubtlessly aware of the consequences to that equity if they discontinue providing liquidity. Still, at some point, one has to question whether this is good money after bad.
    • Entourage has had a remarkable 16 consecutive quarters of negative gross profit. Proforma debt to market cap is approximately 15.8x, which indicates severe distress. Cash flow from operations is running about negative $6-9M per quarter despite not paying interest on the LiUNA facility in cash. Financials do not get much uglier than this.
    • The Viridian Credit Tracker model ranks Entourage as #18 out of the 20 Canadian Cultivation & Retail companies in our database, with market caps between $5M and $50M. The company’s ranking would drop another notch were it not for the liquidity provided by LiUNA.

  • The Viridian Value Tracker shows that Entourage’s peer group trades at approximately 1.6x annualized revenue. Applying this metric to the company’s September quarter gives an estimated enterprise value of $49.3M. Adding in estimated cash of $12M and subtracting $20M of first-priority debt gives a recovery value of approximately $41.4M or roughly 50% of the par value. We believe this valuation is generous and would be sellers at those prices. We would love to attend the LiUNA credit committee meeting when the next round of credit extensions is discussed. We think that will be in around four months.

Week ended 02/10/2023

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

Weekly Credit Tracker

Each week, Viridian highlights a specific industry sector and provides a deep dive into credit metrics and comparable company credit rankings for public companies operating in that sector.  Credit ratings are not currently available for public cannabis companies leaving companies, lenders, and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.

This week’s credit tracker focuses on the 7 Canadian Cultivation & Retail sector companies with market caps between $50M and $500M in the Viridian Value Tracker database in order to make the case that Auxly had a good reason to sell assets, even at prices significantly below its cost:  The firm is over levered and needs to sell assets to reduce debt.  The Viridian Credit tracker ranking system shows Auxly near the bottom of the peer group in terms of credit quality. 

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.